Mehra Rohit, Vats Pankaj, Cieslik Marcin, Cao Xuhong, Su Fengyun, Shukla Sudhanshu, Udager Aaron M, Wang Rui, Pan Jincheng, Kasaian Katayoon, Lonigro Robert, Siddiqui Javed, Premkumar Kumpati, Palapattu Ganesh, Weizer Alon, Hafez Khaled S, Wolf J Stuart, Sangoi Ankur R, Trpkov Kiril, Osunkoya Adeboye O, Zhou Ming, Giannico Giovanna, McKenney Jesse K, Dhanasekaran Saravana M, Chinnaiyan Arul M
Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan.
Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, Michigan.
Cancer Discov. 2016 Nov;6(11):1258-1266. doi: 10.1158/2159-8290.CD-16-0267. Epub 2016 Sep 7.
Mucinous tubular and spindle cell carcinoma (MTSCC) is a relatively rare subtype of renal cell carcinoma (RCC) with distinctive morphologic and cytogenetic features. Here, we carry out whole-exome and transcriptome sequencing of a multi-institutional cohort of MTSCC (n = 22). We demonstrate the presence of either biallelic loss of Hippo pathway tumor suppressor genes (TSG) and/or evidence of alteration of Hippo pathway genes in 85% of samples. PTPN14 (31%) and NF2 (22%) were the most commonly implicated Hippo pathway genes, whereas other genes such as SAV1 and HIPK2 were also involved in a mutually exclusive fashion. Mutations in the context of recurrent chromosomal losses amounted to biallelic alterations in these TSGs. As a readout of Hippo pathway inactivation, a majority of cases (90%) exhibited increased nuclear YAP1 protein expression. Taken together, nearly all cases of MTSCC exhibit some evidence of Hippo pathway dysregulation.
MTSCC is a rare and relatively recently described subtype of RCC. Next-generation sequencing of a multi-institutional MTSCC cohort revealed recurrent chromosomal losses and somatic mutations in the Hippo signaling pathway genes leading to potential YAP1 activation. In virtually all cases of MTSCC, there was evidence of Hippo pathway dysregulation, suggesting a common mechanistic basis for this disease. Cancer Discov; 6(11); 1258-66. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 1197.
黏液性管状和梭形细胞癌(MTSCC)是肾细胞癌(RCC)中一种相对罕见的亚型,具有独特的形态学和细胞遗传学特征。在此,我们对一个多机构队列的MTSCC(n = 22)进行了全外显子组和转录组测序。我们证明,85%的样本中存在Hippo通路肿瘤抑制基因(TSG)的双等位基因缺失和/或Hippo通路基因改变的证据。PTPN14(31%)和NF2(22%)是最常涉及的Hippo通路基因,而其他基因如SAV1和HIPK2也以互斥方式参与其中。在反复出现的染色体缺失背景下的突变相当于这些TSG中的双等位基因改变。作为Hippo通路失活的一个指标,大多数病例(90%)表现出核YAP1蛋白表达增加。综上所述,几乎所有MTSCC病例都表现出一些Hippo通路失调的证据。
MTSCC是一种罕见且相对较新描述的RCC亚型。对一个多机构MTSCC队列进行的下一代测序揭示了Hippo信号通路基因中反复出现的染色体缺失和体细胞突变,导致潜在的YAP1激活。在几乎所有MTSCC病例中,都有Hippo通路失调的证据,提示这种疾病有共同的机制基础。《癌症发现》;6(11);1258 - 66。©2016美国癌症研究协会。本文在本期特刊第1197页被重点介绍。